Cargando…
Insulins as Drugs or Biologics in the USA: What Difference Does it Make and Why Does it Matter?
The status of insulins in the USA is about to change as a regulatory matter. After 23 Mar 2020 they, and other hormone products previously regulated as drugs by the US Food and Drug Administration (FDA), even though biologics in science, will become biologics as a regulatory matter too and will be l...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790337/ https://www.ncbi.nlm.nih.gov/pubmed/31388968 http://dx.doi.org/10.1007/s40259-019-00374-1 |